Preclinical News and Research

RSS

Olive oil's secret weapon against Alzheimer's: phenolic compounds

A comprehensive review in the International Journal of Molecular Sciences highlights the potential of extra-virgin olive oil and its phenolic compounds in preventing and treating Alzheimer's disease through various mechanisms, including reducing amyloid-beta accumulation and neuroinflammation.

12 Feb 2024

Promising new CMV vaccine shows stronger immune response

An experimental mRNA vaccine against human cytomegalovirus (CMV), a common virus that can infect babies during pregnancy, elicited some of the most promising immune responses to date of any CMV vaccine candidate, according to a study by Weill Cornell Medicine investigators.

12 Feb 2024

Immune system in the blood of Alzheimer's patients found to be epigenetically altered

A new Northwestern Medicine study has found the immune system in the blood of Alzheimer's patients is epigenetically altered.

9 Feb 2024

Scientists develop safer CAR T-cell strategy for treating lymphomas

In the treatment of aggressive lymphomas and blood cancer (leukaemia), so-called chimeric antigen receptor T cells (CAR T cells) are increasingly being used.

9 Feb 2024

CARB-X awards $1.8 million to Visby Medical to develop a portable rapid PCR test for gonorrhea

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award up to US$1.8 million to biotechnology company, Visby Medical, to develop a portable rapid polymerase chain reaction (PCR) diagnostic to detect the presence of the pathogen that causes gonorrhea, Neisseria gonorrhoeae (NG), and its susceptibility to ciprofloxacin, a former frontline oral antibiotic that can no longer treat resistant NG.

9 Feb 2024

New treatment targeting aging cells could offer lasting relief for diabetic macular edema

Targeting senescent cells in the retina with a BCL-xL inhibitor shows promise as a durable treatment for diabetic macular edema, potentially offering long-term visual function improvements.

8 Feb 2024

Hope for relapsed myeloma: Preclinical and clinical evidence for ruxolitinib's efficacy

A new research perspective was published in Oncotarget's Volume 15 on February 5, 2024, entitled, "Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma."

8 Feb 2024

Study tracks health and quality of life in chronically critically ill COVID-19 patients months after hospital discharge

Researchers investigated chronic critical illness in COVID-19 survivors who sought ICU admission and were on mechanical ventilation due to severe infection by SARS-CoV-2.

8 Feb 2024

ELRIG UK announces Steve Bates and Dr Anderson Ryan as keynote speakers at Research and Innovation 2024

The European Laboratory Research & Innovation Group (ELRIG) UK today announced the keynote speakers for its upcoming Research and Innovation conference taking place at the University of Manchester from 20–21 March.

From ELRIG (UK) Ltd. 8 Feb 2024

AMG 133 (maridebart cafraglutide) weight loss drug shows promise in early trial

AMG 133, an engineered bispecific molecule, demonstrated significant weight loss with a favorable safety profile in a phase 1 clinical trial, offering a promising new treatment option for obesity.

7 Feb 2024

Experimental mRNA vaccine against CMV elicits promising immune responses

7 Feb 2024

New analysis demonstrates a link between air pollution and cardiovascular disease-related deaths

A recent analysis of data from nearly all World Health Organization member states clearly demonstrates a link between air pollution and mortality from cardiovascular diseases, with more of such deaths associated with air pollution in low-income countries compared with high-income countries.

7 Feb 2024

Patients with non-alcoholic fatty liver disease may benefit from increased dietary niacin intake

Whether higher dietary niacin intake lowers the risk of all-cause, heart and cerebrovascular disease(s).

6 Feb 2024

Pomegranate seed oil boosts brain function in mild cognitive impairment study

Study demonstrates that pomegranate seed oil (PSO) combined with the Mediterranean Diet (MeDi) significantly enhances cognitive functions in individuals with mild cognitive impairment (MCI), suggesting PSO as a potential natural intervention for cognitive health.

5 Feb 2024

Resveratrol can combat Alzheimer's via inflammatory suppression, study shows

Study demonstrates Resveratrol's ability to mitigate Alzheimer's Disease (AD) symptoms by inhibiting proinflammatory responses and promoting antioxidant enzyme expression in microglial cell lines, offering insights into its neuroprotective mechanisms.

5 Feb 2024

SLAS 2024 press release from Veranex

Veranex provider of the first purpose-built, global service platform for the medtech industry, today announced that it has acquired T3 Labs, a highly reputable preclinical laboratory located in Atlanta, Georgia. This acquisition solidifies Veranex’s commitment to expanding its preclinical footprint in North

5 Feb 2024

Preclinical News and Research

Olive oil's secret weapon against Alzheimer's: phenolic compounds

Promising new CMV vaccine shows stronger immune response

Immune system in the blood of Alzheimer's patients found to be epigenetically altered

Scientists develop safer CAR T-cell strategy for treating lymphomas

CARB-X awards $1.8 million to Visby Medical to develop a portable rapid PCR test for gonorrhea

New treatment targeting aging cells could offer lasting relief for diabetic macular edema

Hope for relapsed myeloma: Preclinical and clinical evidence for ruxolitinib's efficacy

Study tracks health and quality of life in chronically critically ill COVID-19 patients months after hospital discharge

ELRIG UK announces Steve Bates and Dr Anderson Ryan as keynote speakers at Research and Innovation 2024

AMG 133 (maridebart cafraglutide) weight loss drug shows promise in early trial

Experimental mRNA vaccine against CMV elicits promising immune responses

New analysis demonstrates a link between air pollution and cardiovascular disease-related deaths

Patients with non-alcoholic fatty liver disease may benefit from increased dietary niacin intake

Pomegranate seed oil boosts brain function in mild cognitive impairment study

Resveratrol can combat Alzheimer's via inflammatory suppression, study shows

SLAS 2024 press release from Veranex

Study links specific inflammatory markers to increased cancer risk

Revvity showcases cutting-edge solutions at SLAS2024

UVA scientists develop new approach to machine learning for identifying heart drug

Breakthrough obesity treatments on the horizon, rivaling surgery's success

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News